A randomized trial Comparing the Effects of Febuxostat and Allopurinol on renal function and left ventricular hypertrophy for chronic heart failure patient with hyperuricemia complicated by chronic kidney disease stage G3-G4.
Latest Information Update: 24 Dec 2019
At a glance
- Drugs Allopurinol (Primary) ; Febuxostat (Primary)
- Indications Chronic heart failure; Hyperuricaemia
- Focus Therapeutic Use
- Acronyms CEFIRO
Most Recent Events
- 31 Jul 2014 New trial record